Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,685 KRW
Change Today +45.00 / 2.74%
Volume 958.7K
As of 2:29 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

yungjin pharmaceutical co (003520) Snapshot

Open
1,640
Previous Close
1,640
Day High
1,690
Day Low
1,640
52 Week High
04/22/15 - 1,930
52 Week Low
12/18/14 - 1,255
Market Cap
299.3B
Average Volume 10 Days
2.6M
EPS TTM
5.00
Shares Outstanding
177.6M
EX-Date
01/4/00
P/E TM
337.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for YUNGJIN PHARMACEUTICAL CO (003520)

Related News

No related news articles were found.

yungjin pharmaceutical co (003520) Related Businessweek News

No Related Businessweek News Found

yungjin pharmaceutical co (003520) Details

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in Korea. Its products include cephalosporin antibiotics, cardiovascular drugs, antipsychotic drugs, tonic drinks, and nutrition agents. The company also offers antibiotic, central nervous system, endocrine, respiratory, analgesic and anti-inflammatory, anti-histamine, anti-fungal, and urinary formulations, as well as vitamins and health supplements, and cosmetic products. Yungjin Pharm. Co., Ltd. was founded in 1952 and is based in Seoul, South Korea.

574 Employees
Last Reported Date: 11/14/13
Founded in 1952

yungjin pharmaceutical co (003520) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yungjin pharmaceutical co (003520) Key Developments

Yungjin Pharm. Co., Ltd., Annual General Meeting, Mar 13, 2015

Yungjin Pharm. Co., Ltd., Annual General Meeting, Mar 13, 2015., at 10:00 Korea Standard Time. Location: 1095 Theatre Prague wedding banquet hall. Agenda: To consider the approval of financial statements and earnings appropriation statement; to consider the election of outside directors; to consider the election of audit committee; and to consider the approval of director remuneration.

Yungjin Pharm. Co., Ltd., Annual General Meeting, Mar 28, 2014

Yungjin Pharm. Co., Ltd., Annual General Meeting, Mar 28, 2014., at 10:00 Korea Standard Time. Location: Cheonho theater as a wedding banquet hall in Prague. Agenda: To consider the approval of financial statements and retained earnings; to consider the election of directors; to consider the election of audit committee of outside directors; and to consider the approval of director remuneration.

Yungjin Pharm. Co., Ltd.(KOSE:A003520) added to KOSPI 200 Index

Yungjin Pharm. Co., Ltd. will be added to KOSPI 200 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003520:KS 1,685.00 KRW +45.00

003520 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003520.
View Industry Companies
 

Industry Analysis

003520

Industry Average

Valuation 003520 Industry Range
Price/Earnings 30.6x
Price/Sales 1.8x
Price/Book 2.9x
Price/Cash Flow 34.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YUNGJIN PHARMACEUTICAL CO, please visit www.yungjin.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.